TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BLLN

BillionToOne, Inc.

Healthcare · Diagnostics & Research

121.70$ -1.1% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns BillionToOne, Inc. (BLLN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.6% of the shares are freely tradable; institutional investors hold 35.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 35.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 37.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 67.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 43Mio.

Largest Shareholders

Institutions

Institutions BLLN
Name Stake (%) Shares Change (%) Date
Adams Street Partners LLC 3.63 1,711,430 +0.0 06/30/2026
Civilization Ventures Management, LLC 2.33 1,099,431 +0.0 03/31/2026
Baillie Gifford & Co Limited. 1.91 901,420 -28.5 06/30/2026
BAMCO Inc 1.57 741,485 +336.2 03/31/2026
T. Rowe Price Associates, Inc. 1.56 737,518 +52.0 03/31/2026
Neuberger Berman Group LLC 1.50 709,214 +1.2 03/31/2026
Wasatch Advisors LP 1.10 518,084 +40.2 06/30/2026

Funds

Funds BLLN
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.54 725,810 -0.1 08/31/2026
Vanguard Small Cap Index 1.11 524,067 +0.0 08/31/2026
Invesco Discovery A 1.03 487,500 +2.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings BLLN
Person Role Shares Value As of Type
Sakakibara Shan Riku Chief Product Officer 196,500 23,914,050 $ Sep 10, 2026 direct
Atay Oguzhan Chairman and CEO 157,168 19,127,346 $ Sep 14, 2026 both
Kolluri Krishna Kittu Director 57,839 7,039,006 $ Aug 26, 2026 indirect
ten Bosch John Roderick SVP of Laboratory Operations 23,635 2,876,380 $ Sep 21, 2026 direct
Tsao David Chief Technology Officer 1,000 121,700 $ Sep 9, 2026 direct
Lynch Thomas P. See Remarks 700 85,190 $ Sep 17, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 21, 2026 ten Bosch John Roderick SVP of Laboratory Operations Sell 1,416 106.61 150,960
Sep 17, 2026 Lynch Thomas P. See Remarks Sell 5,840 110.29 644,112
Sep 17, 2026 Lynch Thomas P. See Remarks Sell 2,920 110.31 322,100
Sep 17, 2026 Lynch Thomas P. See Remarks Sell 6,968 110.30 768,561
Sep 17, 2026 Lynch Thomas P. See Remarks Sell 19,384 110.36 2,139,193
Sep 17, 2026 Lynch Thomas P. See Remarks Other 5,840 30.78 179,755
Sep 17, 2026 Lynch Thomas P. See Remarks Other 2,920 17.12 49,990
Sep 17, 2026 Lynch Thomas P. See Remarks Other 6,968 11.55 80,480
Sep 17, 2026 Lynch Thomas P. See Remarks Other 19,384 8.65 167,672
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 2,666 98.00 261,268
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 3,143 101.49 318,989
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 2,010 100.78 202,559
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 1,500 99.57 149,352
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 1,680 98.64 165,708
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 7,214 101.44 731,793
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 2,531 100.58 254,570
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 2,456 99.57 244,547
Sep 14, 2026 Atay Oguzhan Chairman and CEO Sell 4,465 98.63 440,389
Sep 14, 2026 Atay Oguzhan Chairman and CEO Other 8,333 2.80 23,332
Sep 14, 2026 Atay Oguzhan Chairman and CEO Other 16,666 2.80 46,665
Sep 10, 2026 Sakakibara Shan Riku Chief Product Officer Other 3,500 0.00 –
Sep 9, 2026 Tsao David Chief Technology Officer Sell 10,000 100.00 1,000,000
Sep 9, 2026 Tsao David Chief Technology Officer Other 10,000 2.80 28,000
Sep 9, 2026 ten Bosch John Roderick SVP of Laboratory Operations Sell 1,416 97.54 138,117
Sep 9, 2026 Atay Oguzhan Chairman and CEO Other 20,000 0.00 –
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 232 100.92 23,414
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 2,518 100.20 252,293
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 576 98.89 56,960
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 147 101.41 14,907
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 1,131 100.33 113,469
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 385 99.22 38,201
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 358 100.82 36,095
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 2,997 100.11 300,040
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 614 99.00 60,785
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 775 100.83 78,142
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 8,285 100.12 829,517
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 1,944 98.97 192,390
Sep 8, 2026 Lynch Thomas P. See Remarks Sell 38 96.47 3,666
Sep 8, 2026 Lynch Thomas P. See Remarks Other 3,326 30.78 102,374
Sep 8, 2026 Lynch Thomas P. See Remarks Other 1,663 17.12 28,471
Sep 8, 2026 Lynch Thomas P. See Remarks Other 3,969 11.55 45,842
Sep 8, 2026 Lynch Thomas P. See Remarks Other 11,042 8.65 95,513
Sep 8, 2026 Atay Oguzhan Chairman and CEO Other 20,000 0.00 –
Sep 8, 2026 Tsao David Chief Technology Officer Other 20,000 0.00 –
Sep 3, 2026 Tsao David Chief Technology Officer Other 20,000 0.00 –
Aug 26, 2026 Kolluri Krishna Kittu Director Other 5,644 0.00 –
Aug 26, 2026 Kolluri Krishna Kittu Director Other 15,244 0.00 –
Aug 26, 2026 Kolluri Krishna Kittu Director Other 1,666 0.00 –
Aug 26, 2026 Kolluri Krishna Kittu Director Other 5,761 0.00 –
Aug 26, 2026 Kolluri Krishna Kittu Director Other 719 0.00 –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?